ArticleJACC. Case reports2026
Genetic Reassessment Reveals Catecholaminergic Polymorphic Ventricular Tachycardia in Sisters Initially Diagnosed With Long QT Syndrome.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe QT interval is often prolonged in the immediate postcardiac arrest period, but not all patients with a prolonged QT interval have long QT syndrome (LQTS). CASE SUMMARY: A 29-year-old female was diagnosed with LQTS in childhood based on borderline QTc interval and a family history of a sister with presumed LQTS after cardiac arrest. Updated genetic testing in the proband revealed a likely pathogenic RYR2 variant and a benign KCNE1 variant. Familial testing confirmed that the patient carried the RYR2 variant, establishing a diagnosis of catecholaminergic polymorphic ventricular tachycardia. DISCUSSION: This case underscores the value of confirming the underlying molecular diagnosis in determining arrhythmic risk and guiding family evaluation. Broader or updated genetic testing can clarify disease mechanism, prevent misdirected management, and support targeted risk assessment in relatives. TAKE-HOME MESSAGES: The differential diagnosis of cardiac arrest is broad, including arrhythmia syndromes, arrhythmogenic cardiomyopathy, and nongenetic causes. Comprehensive genetic testing and counseling are essential for informing management of sudden cardiac arrest survivors and their relatives.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.